1. Home
  2. ONBPO vs INM Comparison

ONBPO vs INM Comparison

Compare ONBPO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old National Bancorp

ONBPO

Old National Bancorp

N/A

Current Price

$24.97

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.59

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONBPO
INM
Founded
N/A
1981
Country
United States
Canada
Employees
4948
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ONBPO
INM
Price
$24.97
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1K
33.9K
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,942,633.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.50
52 Week Low
$24.53
$0.58
52 Week High
$25.46
$3.00

Technical Indicators

Market Signals
Indicator
ONBPO
INM
Relative Strength Index (RSI) 52.66 56.97
Support Level $24.89 $1.56
Resistance Level $25.33 $1.91
Average True Range (ATR) 0.15 0.08
MACD 0.01 -0.01
Stochastic Oscillator 80.00 50.00

Price Performance

Historical Comparison
ONBPO
INM

About ONBPO Old National Bancorp

Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: